A Predictive Model of the Health Benefits and Cost Effectiveness of Celiprolol and Atenolol in Primary Prevention of Cardiovascular Disease in Hypertensive Patients

This publication has 73 references indexed in Scilit:

• Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men
  Annals of Internal Medicine, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Cost-effectiveness of Routine Coronary Angiography After Acute Myocardial Infarction
  Circulation, 1996
• Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.
  1995
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Cost-effectiveness analysis of hypertension treatment — A review of methodological issues
  Health Policy, 1991
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
  1991
• Probability of stroke: a risk profile from the Framingham Study.
  Stroke, 1991
• An updated coronary risk profile. A statement for health professionals.
  Circulation, 1991
• A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension
  Current Medical Research and Opinion, 1989